STOCK TITAN

MapLight Therapeutics director proposes $13.4K sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Robert Malenka, a director of MapLight Therapeutics, Inc. (MPLT), gave notice of a proposed sale of 736 common shares, with an aggregate market value of $13,354.72 and an approximate sale date of February 24, 2026. He acquired 736 shares on January 23, 2026 through restricted stock vesting under a registered plan.

The notice also lists prior common-share sales by Malenka dated January 28 through February 23, 2026, with individual amounts and gross proceeds.

Proposed sale 736 common shares Approximate sale date: February 24, 2026
Aggregate market value of proposed sale $13,354.72 Listed for the 736 common shares
Shares acquired through vesting 736 common shares January 23, 2026; restricted stock vesting under a registered plan
Prior sale 11,264 common shares February 23, 2026; gross proceeds of $207,490.76
Gross proceeds $207,490.76 Sale of 11,264 common shares on February 23, 2026
Restricted stock vesting financial
"Restricted stock vesting under a registered plan"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
registered plan regulatory
"vesting under a registered plan"
A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MPLT shares does Robert Malenka plan to sell?

Robert Malenka, a director of MPLT, gave notice of a proposed sale of 736 common shares, listed with an aggregate market value of $13,354.72 and an approximate sale date of February 24, 2026.

How did Robert Malenka acquire the MPLT shares listed for sale?

Malenka acquired the 736 common shares on January 23, 2026 through restricted stock vesting under a registered plan. The acquisition was from the issuer, and the form lists services rendered as the nature of payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading